These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10962642)

  • 1. Investigation of phenobarbital-carbamazepine-valproic acid interactions using population pharmacokinetic analysis for optimisation of antiepileptic drug therapy: an overview.
    Yukawa E
    Drug Metabol Drug Interact; 2000; 16(2):86-98. PubMed ID: 10962642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions among phenobarbital, carbamazepine, and valproic acid in pediatric Japanese patients: clinical considerations on steady-state serum concentration-dose ratios.
    Yukawa E; Hokazono T; Satou M; Ohdo S; Higuchi S; Aoyama T
    Am J Ther; 2000 Sep; 7(5):303-8. PubMed ID: 11317175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model.
    Łuszczki JJ; Marzeda P; Gut-Lepiech A; Kondrat-Wróbel MW; Wróblewska-Łuczka P; Karwan S; Plech T
    Pharmacol Rep; 2019 Apr; 71(2):299-305. PubMed ID: 30826570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based investigation of valproic acid relative clearance using nonlinear mixed effects modeling: influence of drug-drug interaction and patient characteristics.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    J Clin Pharmacol; 1997 Dec; 37(12):1160-7. PubMed ID: 9506012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
    Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
    Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
    Jiao Z; Shi XJ; Zhao ZG; Zhong MK
    J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine diminishes anticonvulsant activity of antiepileptic drugs in mice.
    Czuczwar M; Kiś J; Czuczwar P; Wielosz M; Turski W
    Pol J Pharmacol; 2003; 55(5):799-802. PubMed ID: 14704477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic monitoring of antiepileptic drugs for epilepsy.
    Tomson T; Dahl ML; Kimland E
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002216. PubMed ID: 17253477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of carbamazepine-induced changes in valproic acid relative clearance in man by simple pharmacokinetic screening.
    Yukawa E; Honda T; Ohdo S; Higuchi S; Aoyama T
    J Pharm Pharmacol; 1997 Aug; 49(8):751-6. PubMed ID: 9379350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of a drug-drug interaction on population-based phenobarbitone clearance using nonlinear mixed-effects modeling.
    Yukawa E; To H; Ohdo S; Higuchi S; Aoyama T
    Eur J Clin Pharmacol; 1998 Mar; 54(1):69-74. PubMed ID: 9591934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study to determine the interaction of oxiracetam with antiepileptic drugs.
    van Wieringen A; Meijer JW; van Emde Boas W; Vermeij TA
    Clin Pharmacokinet; 1990 Apr; 18(4):332-8. PubMed ID: 2108837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Kocharov SL; Czuczwar SJ
    Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of carbamazepine drug interaction by multiple peak approach screening using routine clinical pharmacokinetic data.
    Yukawa E; Aoyama T
    J Clin Pharmacol; 1996 Aug; 36(8):752-9. PubMed ID: 8877681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of carbamazepine and phenobarbital in rabbits.
    Rukhadze MD; Alexishvili MM; Okujava NV; Sebiskveradze MV; Okujava VM; Tsagareli SK
    Biomed Chromatogr; 2000 Aug; 14(5):344-8. PubMed ID: 10960836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients.
    Panomvana D; Traiyawong T; Towanabut S
    J Pharm Pharm Sci; 2013; 16(4):502-10. PubMed ID: 24210059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
    Vaz J; Kulkarni C; David J; Joseph T
    Indian J Exp Biol; 1998 Jan; 36(1):112-4. PubMed ID: 9536660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant potency and neurotoxicity of valproate alone and in combination with carbamazepine or phenobarbital.
    Bourgeois BF
    Clin Neuropharmacol; 1988 Aug; 11(4):348-59. PubMed ID: 3145137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of co-medications on lamotrigine clearance in Japanese children with epilepsy.
    Takeuchi T; Natsume J; Kidokoro H; Ishihara N; Yamamoto H; Azuma Y; Ito Y; Kurahashi N; Tsuji T; Suzuki M; Itomi K; Yamada K; Kurahashi H; Abe S; Okumura A; Maruyama K; Negoro T; Watanabe K; Kojima S
    Brain Dev; 2016 Sep; 38(8):723-30. PubMed ID: 27033151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.